It is noteworthy that the delivery system prominently enhanced CD8+ T cells infiltration within tumors up to a depth of 6 mm below the tumor surface, which could address various immune escape issues owing to lack of lymphocytic infiltration in the inner and deep beds of solid tumors by PTT. The gene discussed is CD8A; the disease is neoplasm.